Skip to content
healthcare.dev

DICLOFENAC SODIUM

NDC 84386-103, DICLOFENAC SODIUM, tablet, film coated, extended release, from Aurobindo Pharma Limited.

Product NDC
84386-103
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076152
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84386-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DICLOFENAC SODIUM100 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
84386-103-0184386010301100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-103-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d9b6f1d0-1710-46fb-8ea4-80b3ca60a575

Use it

Look up 84386-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84386-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84386-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.